Global and United States Fecal Pancreatic Elastase Testing Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Fecal pancreatic elastase testing is a kind of test that measures the amount of elastase in the stool. The demand for fecal pancreatic elastase testing is increasing globally due to rising prevalence of exocrine pancreatic insufficiency (EPI).

Market Analysis and Insights: Global and United States Fecal Pancreatic Elastase Testing Market

This report focuses on global and United States Fecal Pancreatic Elastase Testing market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Fecal Pancreatic Elastase Testing market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Fecal Pancreatic Elastase ELISA Kits accounting for % of the Fecal Pancreatic Elastase Testing global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Fecal Pancreatic Elastase Testing market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Fecal Pancreatic Elastase Testing Scope and Market Size
Fecal Pancreatic Elastase Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Fecal Pancreatic Elastase Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Fecal Pancreatic Elastase Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Fecal Pancreatic Elastase ELISA Kits
    Rapid Fecal Pancreatic Elastase Kits

Segment by Application
    Hospitals
    Diagnostics Laboratories
    Specialty Clinics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Labcorp
    DiaSorin
    ScheBo Biotech AG
    Immundiagnostik AG
    Invivo Healthcare
    DRG Instruments GMBH
    Verisana Laboratories
    BÜHLMANN Laboratories AG
    CerTest Biotec
    R-Biopharm AG
    Vitassay Healthcare

 1 Study Coverage
    1.1 Fecal Pancreatic Elastase Testing Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Fecal Pancreatic Elastase Testing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Fecal Pancreatic Elastase Testing Market Size for the Year 2017-2028
        1.2.2 Global Fecal Pancreatic Elastase Testing Market Size for the Year 2017-2028
    1.3 Fecal Pancreatic Elastase Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Fecal Pancreatic Elastase Testing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Fecal Pancreatic Elastase Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Fecal Pancreatic Elastase Testing Market Dynamics
        1.4.1 Fecal Pancreatic Elastase Testing Industry Trends
        1.4.2 Fecal Pancreatic Elastase Testing Market Drivers
        1.4.3 Fecal Pancreatic Elastase Testing Market Challenges
        1.4.4 Fecal Pancreatic Elastase Testing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Fecal Pancreatic Elastase Testing by Type
    2.1 Fecal Pancreatic Elastase Testing Market Segment by Type
        2.1.1 Fecal Pancreatic Elastase ELISA Kits
        2.1.2 Rapid Fecal Pancreatic Elastase Kits
    2.2 Global Fecal Pancreatic Elastase Testing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Fecal Pancreatic Elastase Testing Market Size by Type (2017-2028)
    2.4 United States Fecal Pancreatic Elastase Testing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Fecal Pancreatic Elastase Testing Market Size by Type (2017-2028)

 3 Fecal Pancreatic Elastase Testing by Application
    3.1 Fecal Pancreatic Elastase Testing Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Diagnostics Laboratories
        3.1.3 Specialty Clinics
    3.2 Global Fecal Pancreatic Elastase Testing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Fecal Pancreatic Elastase Testing Market Size by Application (2017-2028)
    3.4 United States Fecal Pancreatic Elastase Testing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Fecal Pancreatic Elastase Testing Market Size by Application (2017-2028)

 4 Global Fecal Pancreatic Elastase Testing Competitor Landscape by Company
    4.1 Global Fecal Pancreatic Elastase Testing Market Size by Company
        4.1.1 Top Global Fecal Pancreatic Elastase Testing Companies Ranked by Revenue (2021)
        4.1.2 Global Fecal Pancreatic Elastase Testing Revenue by Player (2017-2022)
    4.2 Global Fecal Pancreatic Elastase Testing Concentration Ratio (CR)
        4.2.1 Fecal Pancreatic Elastase Testing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Fecal Pancreatic Elastase Testing in 2021
        4.2.3 Global Fecal Pancreatic Elastase Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Fecal Pancreatic Elastase Testing Headquarters, Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Fecal Pancreatic Elastase Testing Headquarters and Area Served
        4.3.2 Global Fecal Pancreatic Elastase Testing Companies Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Fecal Pancreatic Elastase Testing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Fecal Pancreatic Elastase Testing Market Size by Company
        4.5.1 Top Fecal Pancreatic Elastase Testing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Fecal Pancreatic Elastase Testing Revenue by Players (2020, 2021 & 2022)

 5 Global Fecal Pancreatic Elastase Testing Market Size by Region
    5.1 Global Fecal Pancreatic Elastase Testing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Fecal Pancreatic Elastase Testing Market Size by Region (2017-2028)
        5.2.1 Global Fecal Pancreatic Elastase Testing Market Size by Region: 2017-2022
        5.2.2 Global Fecal Pancreatic Elastase Testing Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Fecal Pancreatic Elastase Testing Market Size YoY Growth 2017-2028
        6.1.2 North America Fecal Pancreatic Elastase Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Fecal Pancreatic Elastase Testing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Fecal Pancreatic Elastase Testing Market Size YoY Growth 2017-2028
        6.3.2 Europe Fecal Pancreatic Elastase Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Fecal Pancreatic Elastase Testing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Fecal Pancreatic Elastase Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Fecal Pancreatic Elastase Testing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Fecal Pancreatic Elastase Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Labcorp
        7.1.1 Labcorp Company Details
        7.1.2 Labcorp Business Overview
        7.1.3 Labcorp Fecal Pancreatic Elastase Testing Introduction
        7.1.4 Labcorp Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.1.5 Labcorp Recent Development
    7.2 DiaSorin
        7.2.1 DiaSorin Company Details
        7.2.2 DiaSorin Business Overview
        7.2.3 DiaSorin Fecal Pancreatic Elastase Testing Introduction
        7.2.4 DiaSorin Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.2.5 DiaSorin Recent Development
    7.3 ScheBo Biotech AG
        7.3.1 ScheBo Biotech AG Company Details
        7.3.2 ScheBo Biotech AG Business Overview
        7.3.3 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Introduction
        7.3.4 ScheBo Biotech AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.3.5 ScheBo Biotech AG Recent Development
    7.4 Immundiagnostik AG
        7.4.1 Immundiagnostik AG Company Details
        7.4.2 Immundiagnostik AG Business Overview
        7.4.3 Immundiagnostik AG Fecal Pancreatic Elastase Testing Introduction
        7.4.4 Immundiagnostik AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.4.5 Immundiagnostik AG Recent Development
    7.5 Invivo Healthcare
        7.5.1 Invivo Healthcare Company Details
        7.5.2 Invivo Healthcare Business Overview
        7.5.3 Invivo Healthcare Fecal Pancreatic Elastase Testing Introduction
        7.5.4 Invivo Healthcare Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.5.5 Invivo Healthcare Recent Development
    7.6 DRG Instruments GMBH
        7.6.1 DRG Instruments GMBH Company Details
        7.6.2 DRG Instruments GMBH Business Overview
        7.6.3 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Introduction
        7.6.4 DRG Instruments GMBH Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.6.5 DRG Instruments GMBH Recent Development
    7.7 Verisana Laboratories
        7.7.1 Verisana Laboratories Company Details
        7.7.2 Verisana Laboratories Business Overview
        7.7.3 Verisana Laboratories Fecal Pancreatic Elastase Testing Introduction
        7.7.4 Verisana Laboratories Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.7.5 Verisana Laboratories Recent Development
    7.8 BÜHLMANN Laboratories AG
        7.8.1 BÜHLMANN Laboratories AG Company Details
        7.8.2 BÜHLMANN Laboratories AG Business Overview
        7.8.3 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Introduction
        7.8.4 BÜHLMANN Laboratories AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.8.5 BÜHLMANN Laboratories AG Recent Development
    7.9 CerTest Biotec
        7.9.1 CerTest Biotec Company Details
        7.9.2 CerTest Biotec Business Overview
        7.9.3 CerTest Biotec Fecal Pancreatic Elastase Testing Introduction
        7.9.4 CerTest Biotec Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.9.5 CerTest Biotec Recent Development
    7.10 R-Biopharm AG
        7.10.1 R-Biopharm AG Company Details
        7.10.2 R-Biopharm AG Business Overview
        7.10.3 R-Biopharm AG Fecal Pancreatic Elastase Testing Introduction
        7.10.4 R-Biopharm AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.10.5 R-Biopharm AG Recent Development
    7.11 Vitassay Healthcare
        7.11.1 Vitassay Healthcare Company Details
        7.11.2 Vitassay Healthcare Business Overview
        7.11.3 Vitassay Healthcare Fecal Pancreatic Elastase Testing Introduction
        7.11.4 Vitassay Healthcare Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
        7.11.5 Vitassay Healthcare Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Fecal Pancreatic Elastase Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Fecal Pancreatic Elastase Testing Market Trends
    Table 3. Fecal Pancreatic Elastase Testing Market Drivers
    Table 4. Fecal Pancreatic Elastase Testing Market Challenges
    Table 5. Fecal Pancreatic Elastase Testing Market Restraints
    Table 6. Global Fecal Pancreatic Elastase Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Fecal Pancreatic Elastase Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Fecal Pancreatic Elastase Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Fecal Pancreatic Elastase Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Fecal Pancreatic Elastase Testing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Fecal Pancreatic Elastase Testing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Fecal Pancreatic Elastase Testing Revenue Share by Player, 2017-2022
    Table 13. Global Fecal Pancreatic Elastase Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Fecal Pancreatic Elastase Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Pancreatic Elastase Testing as of 2021)
    Table 15. Top Players of Fecal Pancreatic Elastase Testing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Fecal Pancreatic Elastase Testing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Fecal Pancreatic Elastase Testing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Fecal Pancreatic Elastase Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Fecal Pancreatic Elastase Testing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Fecal Pancreatic Elastase Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Fecal Pancreatic Elastase Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Fecal Pancreatic Elastase Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Fecal Pancreatic Elastase Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Fecal Pancreatic Elastase Testing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Fecal Pancreatic Elastase Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Fecal Pancreatic Elastase Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Fecal Pancreatic Elastase Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Labcorp Company Details
    Table 31. Labcorp Business Overview
    Table 32. Labcorp Fecal Pancreatic Elastase Testing Product
    Table 33. Labcorp Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 34. Labcorp Recent Development
    Table 35. DiaSorin Company Details
    Table 36. DiaSorin Business Overview
    Table 37. DiaSorin Fecal Pancreatic Elastase Testing Product
    Table 38. DiaSorin Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 39. DiaSorin Recent Development
    Table 40. ScheBo Biotech AG Company Details
    Table 41. ScheBo Biotech AG Business Overview
    Table 42. ScheBo Biotech AG Fecal Pancreatic Elastase Testing Product
    Table 43. ScheBo Biotech AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 44. ScheBo Biotech AG Recent Development
    Table 45. Immundiagnostik AG Company Details
    Table 46. Immundiagnostik AG Business Overview
    Table 47. Immundiagnostik AG Fecal Pancreatic Elastase Testing Product
    Table 48. Immundiagnostik AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 49. Immundiagnostik AG Recent Development
    Table 50. Invivo Healthcare Company Details
    Table 51. Invivo Healthcare Business Overview
    Table 52. Invivo Healthcare Fecal Pancreatic Elastase Testing Product
    Table 53. Invivo Healthcare Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 54. Invivo Healthcare Recent Development
    Table 55. DRG Instruments GMBH Company Details
    Table 56. DRG Instruments GMBH Business Overview
    Table 57. DRG Instruments GMBH Fecal Pancreatic Elastase Testing Product
    Table 58. DRG Instruments GMBH Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 59. DRG Instruments GMBH Recent Development
    Table 60. Verisana Laboratories Company Details
    Table 61. Verisana Laboratories Business Overview
    Table 62. Verisana Laboratories Fecal Pancreatic Elastase Testing Product
    Table 63. Verisana Laboratories Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 64. Verisana Laboratories Recent Development
    Table 65. BÜHLMANN Laboratories AG Company Details
    Table 66. BÜHLMANN Laboratories AG Business Overview
    Table 67. BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Product
    Table 68. BÜHLMANN Laboratories AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 69. BÜHLMANN Laboratories AG Recent Development
    Table 70. CerTest Biotec Company Details
    Table 71. CerTest Biotec Business Overview
    Table 72. CerTest Biotec Fecal Pancreatic Elastase Testing Product
    Table 73. CerTest Biotec Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 74. CerTest Biotec Recent Development
    Table 75. R-Biopharm AG Company Details
    Table 76. R-Biopharm AG Business Overview
    Table 77. R-Biopharm AG Fecal Pancreatic Elastase Testing Product
    Table 78. R-Biopharm AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 79. R-Biopharm AG Recent Development
    Table 80. Vitassay Healthcare Company Details
    Table 81. Vitassay Healthcare Business Overview
    Table 82. Vitassay Healthcare Fecal Pancreatic Elastase Testing Product
    Table 83. Vitassay Healthcare Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022) & (US$ Million)
    Table 84. Vitassay Healthcare Recent Development
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
List of Figures
    Figure 1. Fecal Pancreatic Elastase Testing Product Picture
    Figure 2. Global Fecal Pancreatic Elastase Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Fecal Pancreatic Elastase Testing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Fecal Pancreatic Elastase Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Fecal Pancreatic Elastase Testing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Fecal Pancreatic Elastase Testing Market Share in Global 2017-2028
    Figure 7. Fecal Pancreatic Elastase Testing Report Years Considered
    Figure 8. Product Picture of Fecal Pancreatic Elastase ELISA Kits
    Figure 9. Product Picture of Rapid Fecal Pancreatic Elastase Kits
    Figure 10. Global Fecal Pancreatic Elastase Testing Market Share by Type in 2022 & 2028
    Figure 11. Global Fecal Pancreatic Elastase Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Fecal Pancreatic Elastase Testing Market Share by Type (2017-2028)
    Figure 13. United States Fecal Pancreatic Elastase Testing Market Share by Type in 2022 & 2028
    Figure 14. United States Fecal Pancreatic Elastase Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Fecal Pancreatic Elastase Testing Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Diagnostics Laboratories
    Figure 18. Product Picture of Specialty Clinics
    Figure 19. Global Fecal Pancreatic Elastase Testing Market Share by Application in 2022 & 2028
    Figure 20. Global Fecal Pancreatic Elastase Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Fecal Pancreatic Elastase Testing Market Share by Application (2017-2028)
    Figure 22. United States Fecal Pancreatic Elastase Testing Market Share by Application in 2022 & 2028
    Figure 23. United States Fecal Pancreatic Elastase Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Fecal Pancreatic Elastase Testing Market Share by Application (2017-2028)
    Figure 25. North America Fecal Pancreatic Elastase Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. United States Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Fecal Pancreatic Elastase Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Fecal Pancreatic Elastase Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. China Taiwan Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Fecal Pancreatic Elastase Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Colombia Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Fecal Pancreatic Elastase Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Fecal Pancreatic Elastase Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Labcorp Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 54. DiaSorin Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 55. ScheBo Biotech AG Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 56. Immundiagnostik AG Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 57. Invivo Healthcare Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 58. DRG Instruments GMBH Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 59. Verisana Laboratories Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 60. BÜHLMANN Laboratories AG Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 61. CerTest Biotec Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 62. R-Biopharm AG Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 63. Vitassay Healthcare Revenue Growth Rate in Fecal Pancreatic Elastase Testing Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Fecal pancreatic elastase testing is a kind of test that measures the amount of elastase in the stool. The demand for fecal pancreatic elastase testing is increasing globally due to rising prevalence of exocrine pancreatic insufficiency (EPI).

Market Analysis and Insights: Global and United States Fecal Pancreatic Elastase Testing Market

This report focuses on global and United States Fecal Pancreatic Elastase Testing market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Fecal Pancreatic Elastase Testing market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Fecal Pancreatic Elastase ELISA Kits accounting for % of the Fecal Pancreatic Elastase Testing global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Fecal Pancreatic Elastase Testing market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Fecal Pancreatic Elastase Testing Scope and Market Size
Fecal Pancreatic Elastase Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Fecal Pancreatic Elastase Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Fecal Pancreatic Elastase Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Fecal Pancreatic Elastase ELISA Kits
    Rapid Fecal Pancreatic Elastase Kits

Segment by Application
    Hospitals
    Diagnostics Laboratories
    Specialty Clinics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Labcorp
    DiaSorin
    ScheBo Biotech AG
    Immundiagnostik AG
    Invivo Healthcare
    DRG Instruments GMBH
    Verisana Laboratories
    BÜHLMANN Laboratories AG
    CerTest Biotec
    R-Biopharm AG
    Vitassay Healthcare